MX340662B - Una combinación medicinal de ibuprofeno y paracetamol para el tratamiento de osteoartritis y artritis reumatoide. - Google Patents

Una combinación medicinal de ibuprofeno y paracetamol para el tratamiento de osteoartritis y artritis reumatoide.

Info

Publication number
MX340662B
MX340662B MX2011003928A MX2011003928A MX340662B MX 340662 B MX340662 B MX 340662B MX 2011003928 A MX2011003928 A MX 2011003928A MX 2011003928 A MX2011003928 A MX 2011003928A MX 340662 B MX340662 B MX 340662B
Authority
MX
Mexico
Prior art keywords
paracetamol
ibuprofen
treatment
osteoartritis
medicinal combination
Prior art date
Application number
MX2011003928A
Other languages
English (en)
Spanish (es)
Other versions
MX2011003928A (es
Inventor
Campbell Atkinson Hartley
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX340662(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of MX2011003928A publication Critical patent/MX2011003928A/es
Publication of MX340662B publication Critical patent/MX340662B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
MX2011003928A 2008-10-14 2009-10-12 Una combinación medicinal de ibuprofeno y paracetamol para el tratamiento de osteoartritis y artritis reumatoide. MX340662B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ56961208 2008-10-14
PCT/NZ2009/000220 WO2010044681A1 (en) 2008-10-14 2009-10-12 A medicinal product and treatment

Publications (2)

Publication Number Publication Date
MX2011003928A MX2011003928A (es) 2011-08-12
MX340662B true MX340662B (es) 2016-07-20

Family

ID=42106693

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011003928A MX340662B (es) 2008-10-14 2009-10-12 Una combinación medicinal de ibuprofeno y paracetamol para el tratamiento de osteoartritis y artritis reumatoide.

Country Status (29)

Country Link
US (1) US20110166234A1 (https=)
EP (1) EP2341900B1 (https=)
JP (1) JP2012505830A (https=)
KR (1) KR20110112279A (https=)
CN (1) CN102215835A (https=)
AU (1) AU2009304002B9 (https=)
BR (1) BRPI0914086A2 (https=)
CA (1) CA2735834C (https=)
CH (1) CH702339B1 (https=)
CL (1) CL2011000678A1 (https=)
CO (1) CO6341553A2 (https=)
CY (1) CY1122198T1 (https=)
DK (1) DK2341900T3 (https=)
ES (1) ES2725151T3 (https=)
GB (1) GB2476418B (https=)
HR (1) HRP20190891T1 (https=)
HU (1) HUE043063T2 (https=)
LT (1) LT2341900T (https=)
MA (1) MA32635B1 (https=)
MX (1) MX340662B (https=)
MY (1) MY153932A (https=)
NZ (1) NZ591496A (https=)
PL (1) PL2341900T3 (https=)
PT (1) PT2341900T (https=)
RU (1) RU2487707C2 (https=)
SI (1) SI2341900T1 (https=)
TR (2) TR201906742T4 (https=)
WO (1) WO2010044681A1 (https=)
ZA (1) ZA201101752B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE543491T1 (de) 2004-07-07 2012-02-15 Aft Pharmaceuticals Ltd Kombinationspräparat enthaltend ibuprofen und paracetamol
US20130225685A1 (en) * 2010-11-04 2013-08-29 Aft Pharmaceuticals Limited Combination composition
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
CN114681324B (zh) * 2017-07-10 2024-05-03 盖尔凯普科技有限公司 双释放剂型胶囊及其制备方法、装置和系统
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA837556B (en) * 1982-11-15 1984-06-27 Upjohn Co Acetominophen and ibuprofen/flurbiprofen
EP0109281A1 (en) * 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
ATE543491T1 (de) * 2004-07-07 2012-02-15 Aft Pharmaceuticals Ltd Kombinationspräparat enthaltend ibuprofen und paracetamol
GB0519350D0 (en) * 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
TR201102810T2 (tr) 2011-05-23
CH702339B1 (de) 2016-06-15
RU2487707C2 (ru) 2013-07-20
NZ591496A (en) 2012-12-21
KR20110112279A (ko) 2011-10-12
CO6341553A2 (es) 2011-11-21
ZA201101752B (en) 2012-02-29
GB2476418B (en) 2013-04-24
AU2009304002A1 (en) 2010-04-22
CA2735834C (en) 2017-05-16
WO2010044681A1 (en) 2010-04-22
TR201906742T4 (tr) 2019-05-21
MA32635B1 (fr) 2011-09-01
MX2011003928A (es) 2011-08-12
JP2012505830A (ja) 2012-03-08
PL2341900T3 (pl) 2019-08-30
ES2725151T3 (es) 2019-09-19
CN102215835A (zh) 2011-10-12
EP2341900A4 (en) 2012-02-29
AU2009304002B9 (en) 2014-06-26
SI2341900T1 (sl) 2019-06-28
EP2341900A1 (en) 2011-07-13
DK2341900T3 (da) 2019-05-20
EP2341900B1 (en) 2019-02-20
US20110166234A1 (en) 2011-07-07
CY1122198T1 (el) 2020-11-25
GB201105249D0 (en) 2011-05-11
HRP20190891T1 (hr) 2019-07-12
CA2735834A1 (en) 2010-04-22
BRPI0914086A2 (pt) 2020-01-21
GB2476418A (en) 2011-06-22
RU2011111792A (ru) 2012-11-27
PT2341900T (pt) 2019-05-14
CL2011000678A1 (es) 2011-09-23
LT2341900T (lt) 2019-04-10
HUE043063T2 (hu) 2019-07-29
MY153932A (en) 2015-04-15
AU2009304002B2 (en) 2013-04-18

Similar Documents

Publication Publication Date Title
MX340662B (es) Una combinación medicinal de ibuprofeno y paracetamol para el tratamiento de osteoartritis y artritis reumatoide.
CY1120389T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει εναν glp-1-αγωνιστη, μια ινσουλινη και μεθειονινη
CL2013000063A1 (es) Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion.
CL2008000418A1 (es) Uso de un antagonista de la il-23 para el tratamiento de una infeccion fungica.
CL2011001497A1 (es) Compuestos derivados de heterociclos, modulador de gpr120; composicion farmaceutica; y su uso para el tratamiento de diabetes tipo i,ii y sindrome metabolico.
CL2011000562A1 (es) Compuesto derivado de tetraciclina; util en el tratamiento de artritis reumatoide.
MX2019008148A (es) Uso de peptidos glp-1 de accion prolongada.
CL2012000319A1 (es) Uso de una composición farmaceutica que comprende treprostinil para la preparación de un medicamento para el tratamiento o la prevención de una afección asociada a la fibrosis quística.
EP4252801A3 (en) Chemical engines and methods for their use, especially in the injection of highly viscous fluids
CL2012003281A1 (es) Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica.
CL2011000527A1 (es) Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c.
CR10347A (es) Anticuerpos contra el peptidob-amiloide
UY33445A (es) Un régimen de dosificación, métodos para tratar el virus de la hepatitis c, composición farmacéutica, compuesta, compuestos anti-hcv y kit
CR11418A (es) Trans-clomifeno para el sindrome metabolico
BRPI0817237A2 (pt) Métodos e formulações para converter fármacos intravenosos e injetáveis em formas de dosagem oral
PE20151079A1 (es) Tratamiento para artritis reumatoide
CY1121852T1 (el) Μορφοποιησεις και μεθοδοι παρασκευης μορφοποιησεων για χρηση στον καθαρισμο του παχεος εντερου
BRPI0818323A2 (pt) composição farmacêutica, uso de uma composição farmacêutica, e, método para tratar câncer.
CY1118912T1 (el) Πηκτωματουμενο κολλαγονο και μεσο για τη διαθεση αυτου
ECSP11010811A (es) Uso de dronedarona para la preparación de un medicamento para la prevención de ictus o ataque isquémico transitorio
CL2012003265A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de enfermedades infecciosas; composicion farmacéutica y/o dermocosmética antiinflamatoria que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo.
CL2015000415A1 (es) Peptido sintético pntx (19) composiciones farmacéuticas y uso
CL2011000388A1 (es) Combinacion farmaceutica que comprende (6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol y un antiinflamatorio no esteroidal; forma de dosificacion; uso en el tratamiento de la osteoartritis y el dolor.
EA200900259A1 (ru) Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
ECSP10010661A (es) Dronedarona para la prevención de la cardioversión

Legal Events

Date Code Title Description
FG Grant or registration